Home›Trial›NCT06138613
🔬NCT06138613Phase 3ACTIVE NOT RECRUITING

Motion Delos: An Open Label Safety and Efficacy of Tradipitant in Participants Affected by Motion Sickness

Study Summary

An open label study to investigate the safety and efficacy of tradipitant in participants affected by motion sickness during travel

Conditions
Motion Sickness
Interventions / Drugs
Tradipitant
View on ClinicalTrials.gov ↗
Sponsor
VNDA
Vanda Pharmaceuticals
Neuroscience
D38/100
Study Details
Enrollment705 participants
Primary Completion—
Lead SponsorVanda Pharmaceuticals
Data Retrieved2026-04-11 04:31:05.188511+00:00
Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.